IRIS Accounts Production v25.4.0.155 10694656 director 1.4.24 31.3.25 31.3.25 false true false false true false iso4217:GBP iso4217:USD iso4217:EUR xbrli:shares xbrli:pure utr:tonnes utr:kWh 10694656 2024-03-31 10694656 2025-03-31 10694656 2024-04-01 2025-03-31 10694656 2023-03-31 10694656 2023-04-01 2024-03-31 10694656 2024-03-31 10694656 ns15:EnglandWales 2024-04-01 2025-03-31 10694656 ns14:PoundSterling 2024-04-01 2025-03-31 10694656 ns10:Director1 2024-04-01 2025-03-31 10694656 ns10:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 10694656 ns10:SmallEntities 2024-04-01 2025-03-31 10694656 ns10:AuditExemptWithAccountantsReport 2024-04-01 2025-03-31 10694656 ns10:SmallCompaniesRegimeForDirectorsReport 2024-04-01 2025-03-31 10694656 ns10:SmallCompaniesRegimeForAccounts 2024-04-01 2025-03-31 10694656 ns10:FullAccounts 2024-04-01 2025-03-31 10694656 ns10:RegisteredOffice 2024-04-01 2025-03-31 10694656 ns5:CurrentFinancialInstruments 2025-03-31 10694656 ns5:CurrentFinancialInstruments 2024-03-31 10694656 ns5:ShareCapital 2025-03-31 10694656 ns5:ShareCapital 2024-03-31 10694656 ns5:RetainedEarningsAccumulatedLosses 2025-03-31 10694656 ns5:RetainedEarningsAccumulatedLosses 2024-03-31 10694656 ns5:PlantMachinery 2024-04-01 2025-03-31 10694656 ns5:PlantMachinery 2024-03-31 10694656 ns5:PlantMachinery 2025-03-31 10694656 ns5:PlantMachinery 2024-03-31 10694656 ns10:Director1 1 2024-03-31 10694656 ns10:Director1 1 2023-03-31 10694656 ns10:Director1 1 2024-04-01 2025-03-31 10694656 ns10:Director1 1 2023-04-01 2024-03-31 10694656 ns10:Director1 1 2025-03-31 10694656 ns10:Director1 1 2024-03-31

REGISTERED NUMBER: 10694656 (England and Wales)

UNAUDITED FINANCIAL STATEMENTS |

| FOR THE YEAR ENDED 31 MARCH 2025 |

| FOR |

| WYE VALLEY OSTEOPATHY LIMITED |

WYE VALLEY OSTEOPATHY LIMITED (REGISTERED NUMBER: 10694656) |

CONTENTS OF THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 March 2025

Page |

| Company information | 1 |

| Balance sheet | 2 |

| Notes to the financial statements | 3 |

| Chartered accountants' report | 5 |

| WYE VALLEY OSTEOPATHY LIMITED |

COMPANY INFORMATION

FOR THE YEAR ENDED 31 March 2025

| DIRECTOR: | Ms L L B Booth

| REGISTERED OFFICE: | 66 Hinton Road

| Hereford

| Herefordshire

| HR2 6BN

| REGISTERED NUMBER: | 10694656 (England and Wales)

| ACCOUNTANTS: | Mitchell Glanville Limited

| 2nd Floor

| Cumberland House

| Oriel Road

| Cheltenham

| Gloucestershire

| GL50 1BB

WYE VALLEY OSTEOPATHY LIMITED (REGISTERED NUMBER: 10694656) |

BALANCE SHEET

31 March 2025

| 2025 | 2024 |

| Notes | £ | £ | £ | £ |

FIXED ASSETS

Tangible assets | 4 | 211 |  | 282 |  |

CURRENT ASSETS

Cash at bank | 7,822 |  | 6,907 |  |

CREDITORS

Amounts falling due within one year | 5 | 7,970 |  | 5,610 |  |

NET CURRENT (LIABILITIES)/ASSETS | (148 | ) | 1,297 |  |

TOTAL ASSETS LESS CURRENT LIABILITIES | 63 |  | 1,579 |  |

CAPITAL AND RESERVES

Called up share capital | 1 |  | 1 |  |

Retained earnings | 62 |  | 1,578 |  |

SHAREHOLDERS' FUNDS | 63 |  | 1,579 |  |

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2025 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for:

(a) | ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b) | preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 24 November 2025 and were signed by:

Ms L L B Booth - Director

WYE VALLEY OSTEOPATHY LIMITED (REGISTERED NUMBER: 10694656) |

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 March 2025

1. | STATUTORY INFORMATION

| Wye Valley Osteopathy Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. | ACCOUNTING POLICIES

| BASIS OF PREPARING THE FINANCIAL STATEMENTS

| These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

| TURNOVER

| Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

| TANGIBLE FIXED ASSETS

| Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

| Plant and machinery | - | 25% on reducing balance

| TAXATION

| Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

| Current or deferred taxation assets and liabilities are not discounted.

| Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

3. | EMPLOYEES AND DIRECTORS

| The average number of employees during the year was 1 (2024 - 1 ) .

4. | TANGIBLE FIXED ASSETS

| Plant and

| machinery

£ |

| COST

| At 1 April 2024

| and 31 March 2025 | 1,551 |  |

| DEPRECIATION

| At 1 April 2024 | 1,269 |  |

| Charge for year | 71 |  |

| At 31 March 2025 | 1,340 |  |

| NET BOOK VALUE

| At 31 March 2025 | 211 |  |

| At 31 March 2024 | 282 |  |

5. | CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |

2025 | 2024 |

£ | £ |

| Taxation and social security | 6,745 |  | 5,226 |  |

| Other creditors | 1,225 |  | 384 |  |

7,970 |  | 5,610 |  |

WYE VALLEY OSTEOPATHY LIMITED (REGISTERED NUMBER: 10694656) |

NOTES TO THE FINANCIAL STATEMENTS - continued

FOR THE YEAR ENDED 31 March 2025

6. | DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES

| The following advances and credits to a director subsisted during the years ended 31 March 2025 and 31 March 2024:

2025 | 2024 |

£ | £ |

| Ms L L B Booth

| Balance outstanding at start of year | (110 | ) | (38 | ) |

| Amounts advanced | 200 |  | 26,033 |  |

| Amounts repaid | (906 | ) | (26,105 | ) |

| Amounts written off | - |  | - |  |

| Amounts waived | - |  | - |  |

| Balance outstanding at end of year | (816 | ) | (110 | ) |

| At the balance sheet date the company owed the director £816 (2024 £110). The loan has no repayment terms or interest.

CHARTERED ACCOUNTANTS' REPORT TO THE DIRECTOR

ON THE UNAUDITED FINANCIAL STATEMENTS OF

WYE VALLEY OSTEOPATHY LIMITED

The following reproduces the text of the report prepared for the director in respect of the company's annual unaudited financial statements. In accordance with the Companies Act 2006, the company is only required to file a Balance sheet. Readers are cautioned that the Income statement and certain other primary statements and the Report of the director are not required to be filed with the Registrar of Companies.

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Wye Valley Osteopathy Limited for the year ended 31 March 2025 which comprise the Income statement, Balance sheet, Statement of changes in equity and the related notes from the company's accounting records and from information and explanations you have given us.

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed within the ICAEW's regulations and guidance at http://www.icaew.com/en/membership/regulations-standards-and-guidance.

This report is made solely to the director of Wye Valley Osteopathy Limited in accordance with our terms of engagement. Our work has been undertaken solely to prepare for your approval the financial statements of Wye Valley Osteopathy Limited and state those matters that we have agreed to state to the director of Wye Valley Osteopathy Limited in this report in accordance with ICAEW Technical Release 07/16AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Wye Valley Osteopathy Limited and its director for our work or for this report.

It is your duty to ensure that Wye Valley Osteopathy Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of Wye Valley Osteopathy Limited. You consider that Wye Valley Osteopathy Limited is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the financial statements of Wye Valley Osteopathy Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.

Mitchell Glanville Limited

2nd Floor

Cumberland House

Oriel Road

Cheltenham

Gloucestershire

GL50 1BB

Date: .............................................